Insider Transactions in Q2 2023 at Cns Pharmaceuticals, Inc. (CNSP)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 28
2023
|
Christopher Downs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+5.06%
|
-
|
|
Apr 28
2023
|
John M Climaco Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+2.63%
|
-
|
|
Apr 19
2023
|
Jerzy Gumulka Director |
BUY
Open market or private purchase
|
Direct |
2,500
+20.54%
|
$2,500
$1.7 P/Share
|
|
Apr 17
2023
|
Christopher Downs Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,100
+25.1%
|
$9,300
$3.2 P/Share
|
|
Apr 12
2023
|
John M Climaco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+25.0%
|
$0
$0.69 P/Share
|
|
Apr 10
2023
|
Jerzy Gumulka Director |
BUY
Open market or private purchase
|
Direct |
7,173
+50.0%
|
$0
$0.74 P/Share
|